Vivoryon Therapeutics Eulerpool Nyheder

Vivoryon Therapeutics Aktie Nyheder

Vivoryon Therapeutics bliver overvåget af mange journalister og investorer over hele verden. De seneste Vivoryon Therapeutics nyheder samler vi her.

• 10. december ·

  Yahoo
  New strategy for Vivoryon as second failed Alzheimer’s trial shows kidney promise
• 10. december ·

  Yahoo
  Vivoryon Therapeutics N.V. Reports Q3 2024 Results and Highlights Progress on Varoglutamstat in Kidney Disease
• 10. december ·

  Yahoo
  Promising Penny Stocks To Consider In December 2024
• 9. december ·

  Yahoo
  Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function
• 4. december ·

  Yahoo
  Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024
• 26. oktober ·

  Yahoo
  Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
• 11. oktober ·

  Yahoo
  Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
• 1. oktober ·

  Yahoo
  Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event
• 26. september ·

  Yahoo
  This Vivoryon Therapeutics Insider Increased Their Holding By 143% Last Year
• 12. september ·

  Yahoo
  Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease